- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
- 10-K Annual report
- 10.5.1 First Amendment to Lease Dated December 2003
- 10.5.2 Second Amendment to Lease Dated November 18, 2008
- 10.5.3 Third Amendment to Lease Dated March 25, 2009
- 23 Consent of Moss Adams LLP, Independent Registered Public Accounting Firm
- 31.1 Section 302 CEO Certification
- 31.2 Section 302 CFO Certification
- 32.1 Section 906 CEO Certification
- 32.2 Section 906 CFO Certification
EXHIBIT 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to incorporation by reference in the registration statements on Form S-8 (Nos. 033-94400, 033-56454, 033-42156, 333-37017, 333-38206, 333-38212, 333-48632, 333-48634, 333-73868, 333-108514 333-128618 and 333-153195) of Bioject Medical Technologies Inc. of our report dated March 31, 2009, related to the consolidated balance sheets of Bioject Medical Technologies Inc. as of December 31, 2008 and 2007, and the related consolidated statements of operations, shareholders’ equity and cash flows for each of the years in the two-year period ended December 31, 2008, which appears in the December 31, 2008 Annual Report on Form 10-K of Bioject Medical Technologies Inc.
Our audit report dated March 31, 2009, contains an explanatory paragraph that states that the Company’s recurring losses, negative cash flows from operations, and accumulated deficit raise substantial doubt about the entity’s ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of that uncertainty.
/s/ Moss Adams LLP
Portland, Oregon
March 31, 2009